港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

生物醫藥B類股

437.197

+6.7341.56%

漲家數：13

跌家數：17

平家數：4

市盈率：- -

高：444.607

開：430.463

低：424.474

收：430.463

資料載入中...

港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式產品發展未來可期

歌禮制藥-B盤中異動股價大漲5.14%

中國抗體-B盤中異動股價大漲6.19%報1.200港元

諾誠健華盤中異動早盤股價大漲5.05%

加科思-B盤中異動早盤股價大漲5.32%

歸創通橋-B盤中異動股價大漲5.28%

騰盛博藥-B盤中異動早盤急速上漲5.16%報2.240港元

貝康醫療-B盤中異動快速上漲7.19%報3.430港元

【創新藥板塊短線拉昇一品紅漲超10%】創新藥板塊短線拉昇，一品紅漲超10%，諾思格、海創藥業、盟科藥業、博騰股份、皓元醫藥等跟漲。

A股創新藥板塊短線拉昇，一品紅漲超10%，諾思格、海創藥業、盟科藥業、博騰股份、皓元醫藥等跟漲。

兆科眼科-B盤中異動急速拉昇5.26%

耐立克®治療費城染色體陽性（Ph+）急性淋巴細胞白血病（ALL）獲突破性療法認定

基石藥業-B盤中異動大幅拉昇5.04%報3.750港元

永泰生物-B盤中異動早盤股價大漲5.62%

邁博藥業-B盤中異動早盤急速上漲6.06%

華領醫藥-B盤中異動早盤快速上漲5.33%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":437.19687,"timestamp":1741334919603,"preClose":430.4633,"halted":0,"volume":156813444,"delay":0,"changeRate":0.015643,"change":6.733582,"pbRate":3.43319,"amount":2812448156,"amplitude":0.046771,"prevYearClose":331.1933,"fiveDayClose":411.011,"twentyDayClose":335.39,"turnoverRate":0.005967,"marketCap":244193759232,"floatMarketCap":230149584960,"peRate":-17.305245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":444.6071,"amplitude":0.046771,"preClose":430.4633,"low":424.47403,"pbRate":"3.43319","latestPrice":437.19687,"volume":156813444,"delay":0,"open":430.4633,"prevYearClose":331.1933,"prevWeekClose":437.197,"prevMonthClose":411.011,"prevQuarterClose":331.193,"fiveDayClose":411.011,"twentyDayClose":335.39,"sixtyDayClose":340.535,"secType":"PLATE","market":"HK","turnoverRate":0.005967,"peRate":-17.305245,"marketCap":244193759232,"floatMarketCap":230149584960,"timestamp":1741334919603,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":13,"down":17,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:16,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517908031","title":"港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式 產品發展未來可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908031","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908031?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:22","pubTimestamp":1741227746,"startTime":"0","endTime":"0","summary":"中信建投发布研报称，歌礼制药-B发布公告，其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示，前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。该行认为，全球减重药物市场规模蓬勃成长，众多超重或肥胖成年人群急需创新药物来改善并提高生活质量，在此基础下，公司的两款药物ASC30、ASC47均具备差异化设计方式，产品发展未来可期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","BK1161","01672","BK1574","01477"],"gpt_icon":0},{"id":"2517908542","title":"歌禮制藥-B盤中異動 股價大漲5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908542?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:19","pubTimestamp":1741227599,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时19分，歌礼制药-B股票出现波动，股价急速上涨5.14%。截至发稿，该股报7.360港元/股，成交量325.1万股，换手率0.34%，振幅5.29%。资金方面，该股资金流入953.631万港元，流出1142.22万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.00%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","01672","BK1515","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2517035289","title":"中國抗體-B盤中異動 股價大漲6.19%報1.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517035289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517035289?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:03","pubTimestamp":1741226617,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时03分，中国抗体-B股票出现异动，股价快速上涨6.19%。截至发稿，该股报1.200港元/股，成交量11.73万股，换手率0.01%，振幅6.19%。资金方面，该股资金流入12.8622万港元，流出1.1202万港元。中国抗体-B股票所在的生物技术行业中，整体涨幅为2.26%。中国抗体-B公司简介：中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306100337963b8092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306100337963b8092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2517970556","title":"諾誠健華盤中異動 早盤股價大漲5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970556?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:59","pubTimestamp":1741226393,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时59分，诺诚健华股票出现异动，股价快速上涨5.05%。截至发稿，该股报9.980港元/股，成交量189.5万股，换手率0.13%，振幅5.05%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。诺诚健华股票所在的生物技术行业中，整体涨幅为2.31%。其相关个股中，复宏汉霖、加科思-B、昭衍新药涨幅较大，振幅较大的相关个股有创胜集团-B、复宏汉霖、腾盛博药-B，振幅分别为11.18%、10.36%、10.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095953abea7a1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095953abea7a1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688428","BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2517970891","title":"加科思-B盤中異動 早盤股價大漲5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970891?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:57","pubTimestamp":1741226263,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时57分，加科思-B股票出现异动，股价急速上涨5.32%。截至发稿，该股报2.770港元/股，成交量334.23万股，换手率0.42%，振幅5.70%。加科思-B股票所在的生物技术行业中，整体涨幅为2.17%。其相关个股中，腾盛博药-B、复宏汉霖、宜明昂科-B涨幅较大，振幅较大的相关个股有创胜集团-B、腾盛博药-B、贝康医疗-B，振幅分别为11.18%、9.39%、9.38%。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095743abea7927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095743abea7927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2517970809","title":"歸創通橋-B盤中異動 股價大漲5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970809?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:57","pubTimestamp":1741226245,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时57分，归创通桥-B股票出现波动，股价大幅拉升5.28%。截至发稿，该股报12.760港元/股，成交量9.25万股，换手率0.03%，振幅4.95%。资金方面，该股资金流入75.77万港元，流出13.599万港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。其相关个股中，心通医疗-B、沛嘉医疗-B、先健科技涨幅较大，振幅较大的相关个股有心通医疗-B、GUANZE MEDICAL、沛嘉医疗-B，振幅分别为9.90%、8.82%、6.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095725a2618f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095725a2618f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02190","BK1100","BK1587","BK1583","BK1574"],"gpt_icon":0},{"id":"2517803970","title":"騰盛博藥-B盤中異動 早盤急速上漲5.16%報2.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517803970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517803970?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:52","pubTimestamp":1741225961,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时52分，腾盛博药-B股票出现异动，股价急速上涨5.16%。截至发稿，该股报2.240港元/股，成交量175.85万股，换手率0.24%，振幅7.51%。资金方面，该股资金流入146.548万港元，流出191.013万港元。腾盛博药-B股票所在的生物技术行业中，整体涨幅为1.59%。腾盛博药-B公司简介：腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095241989de441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306095241989de441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"gpt_icon":0},{"id":"2517970806","title":"貝康醫療-B盤中異動 快速上漲7.19%報3.430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970806?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:49","pubTimestamp":1741225763,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时49分，贝康医疗-B股票出现波动，股价急速拉升7.19%。截至发稿，该股报3.430港元/股，成交量1000股，换手率0.00%，振幅7.19%。资金方面，该股资金流入3315港元，流出0港元。贝康医疗-B股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，科伦博泰生物-B、贝康医疗-B、复宏汉霖涨幅较大，振幅较大的相关个股有创胜集团-B、复宏汉霖、华领医药-B，振幅分别为11.18%、8.04%、7.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094923989de2cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094923989de2cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02170","BK1574","BK1222","BK1597"],"gpt_icon":0},{"id":"2517375977","title":"【創新藥板塊短線拉昇 一品紅漲超10%】創新藥板塊短線拉昇，一品紅漲超10%，諾思格、海創藥業、盟科藥業、博騰股份、皓元醫藥等跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517375977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517375977?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:45","pubTimestamp":1741225532,"startTime":"0","endTime":"0","summary":"创新药板块短线拉升，一品红涨超10%，诺思格、海创药业、盟科药业、博腾股份、皓元医药等跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06094548554912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300723","BK0239","300363","BK1161","688373","06978","688302","301333","688131","BK0028","BK1574","BK0216","159992"],"gpt_icon":0},{"id":"2517778729","title":"A股創新藥板塊短線拉昇，一品紅漲超10%，諾思格、海創藥業、盟科藥業、博騰股份、皓元醫藥等跟漲。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517778729","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517778729?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:44","pubTimestamp":1741225479,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06978","BK0028","BK0239","399300","BK1574","BK1161","300363","159992","688131","BK0216","688302","301333","688373","159982","300723"],"gpt_icon":0},{"id":"2517577908","title":"兆科眼科-B盤中異動 急速拉昇5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517577908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517577908?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:43","pubTimestamp":1741225439,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时43分，兆科眼科-B股票出现异动，股价快速上涨5.26%。截至发稿，该股报2.200港元/股，成交量135.65万股，换手率0.25%，振幅4.78%。兆科眼科-B股票所在的药品行业中，整体涨幅为0.19%。其相关个股中，德琪医药-B、兆科眼科-B、精优药业涨幅较大，振幅较大的相关个股有顺腾国际控股、德琪医药-B、兴科蓉医药，振幅分别为11.54%、8.16%、5.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094359989de08b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094359989de08b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1191","06622","BK1583"],"gpt_icon":0},{"id":"2517908543","title":"耐立克®治療費城染色體陽性（Ph+）急性淋巴細胞白血病（ALL）獲突破性療法認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908543","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908543?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:42","pubTimestamp":1741225320,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州2025年3月6日 /美通社/ -- 致力于在血液肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布，公司原创1类新药奥雷巴替尼获国家药品监督管理局药品审评中心纳入\"突破性治疗品种\"名单，用于联合化疗一线治疗新诊断费城染色体阳性（Ph+）急性淋巴细胞白血病患者。此次耐立克获纳入突破性治疗品种，显示了该药物在Ph+ ALL这一预后恶劣的血液肿瘤治疗领域具重大临床潜力和价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4634781_ZH34781_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1571399168.USD","LU0985320562.USD","LU2355687059.USD","LU1699723380.USD","BK1161","BK4588","06855","ALL","BK4585","BK4139","BK1574","BK4107","AAPG","BK4533"],"gpt_icon":0},{"id":"2517972404","title":"基石藥業-B盤中異動 大幅拉昇5.04%報3.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517972404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517972404?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:41","pubTimestamp":1741225285,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时41分，基石药业-B股票出现波动，股价快速上涨5.04%。截至发稿，该股报3.750港元/股，成交量184.35万股，换手率0.14%，振幅4.76%。资金方面，该股资金流入426.485万港元，流出177.93万港元。基石药业-B股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，科伦博泰生物-B、创胜集团-B、复宏汉霖涨幅较大，振幅较大的相关个股有华领医药-B、复宏汉霖、百奥赛图-B，振幅分别为7.79%、6.96%、6.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094125a2618866&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094125a2618866&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2517373970","title":"永泰生物-B盤中異動 早盤股價大漲5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517373970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517373970?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:41","pubTimestamp":1741225265,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时41分，永泰生物-B股票出现异动，股价急速拉升5.62%。永泰生物-B股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，创胜集团-B、复宏汉霖、科伦博泰生物-B涨幅较大，振幅较大的相关个股有华领医药-B、复宏汉霖、百奥赛图-B，振幅分别为7.79%、6.96%、6.79%。永泰生物-B公司简介：永泰生物制药有限公司是一家主要从事用于治疗癌症的细胞免疫产品的研发、制造及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094108963b76f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094108963b76f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978"],"gpt_icon":0},{"id":"2517972476","title":"邁博藥業-B盤中異動 早盤急速上漲6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517972476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517972476?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:40","pubTimestamp":1741225229,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时40分，迈博药业-B股票出现异动，股价快速上涨6.06%。截至发稿，该股报0.350港元/股，成交量1.6万股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.93%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"gpt_icon":0},{"id":"2517970360","title":"華領醫藥-B盤中異動 早盤快速上漲5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970360?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:36","pubTimestamp":1741225003,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时36分，华领医药-B股票出现波动，股价快速上涨5.33%。截至发稿，该股报2.570港元/股，成交量180.55万股，换手率0.17%，振幅6.97%。华领医药-B股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，创胜集团-B、宜明昂科-B、科伦博泰生物-B涨幅较大，振幅较大的相关个股有华领医药-B、百奥赛图-B、昭衍新药，振幅分别为6.97%、6.79%、5.44%。华领医药-B公司简介：华领医药是一家主要从事药物开发业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093643963b7525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093643963b7525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","02552"],"gpt_icon":0}],"pageSize":16,"totalPage":46,"pageCount":10,"totalSize":724}]}}